Piramal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

1,322.95

1,193.32

1,185.91

994.60

Share application money

-

-

-

0.10

Preference share capital

-

-

-

-

Reserves & surplus

5,389.12

4,068.47

3,881.43

3,105.92

Loan funds

Secured loans

1,151.89

1,627.28

1,101.53

165.20

Unsecured loans

-

-

-

-

Total

7,863.96

6,889.07

6,168.87

4,265.82

Uses of funds

Fixed assets

Gross block

3,409.38

3,263.22

2,123.42

2,064.23

Less : revaluation reserve

-

-

-

-

Less : accumulated depreciation

797.22

661.35

514.44

437.42

Net block

2,612.16

2,601.87

1,608.98

1,626.81

Capital work-in-progress

533.24

416.57

205.10

121.00

Investments

1,708.16

1,746.99

2,634.29

1,591.52

Net current assets

Current assets, loans & advances

4,697.32

3,276.97

2,759.95

2,417.34

Less : current liabilities & provisions

1,686.92

1,153.33

1,039.45

1,490.85

Total net current assets

3,010.40

2,123.64

1,720.50

926.49

Miscellaneous expenses not written

-

-

-

-

Total

7,863.96

6,889.07

6,168.87

4,265.82

Notes:

Book value of unquoted investments

1,646.88

1,646.83

2,634.29

1,591.52

Market value of quoted investments

-

-

-

-

Contingent liabilities

190.29

150.70

101.97

75.22

Number of equity sharesoutstanding (Lacs)

13229.48

11933.19

11859.14

9946.02